These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28434260)

  • 21. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
    Arunthathi S; Raju S
    Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dapsone syndrome.
    Dhamija R; Kumar D; Khurana G
    Trop Doct; 1995 Oct; 25(4):176-7. PubMed ID: 7502329
    [No Abstract]   [Full Text] [Related]  

  • 24. Dapsone hypersensitivity syndrome: a clinico-epidemiological review.
    Agrawal S; Agarwalla A
    J Dermatol; 2005 Nov; 32(11):883-9. PubMed ID: 16361748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies.
    Chun JS; Yun SJ; Kim SJ; Lee SC; Won YH; Lee JB
    Clin Exp Dermatol; 2009 Dec; 34(8):e798-801. PubMed ID: 19778310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin eruption and thrombocytopaenia in a woman with glaucoma: a case report.
    Santos VM; Castro RA; Lima CC; Moraes MB; Sugai TA
    West Indian Med J; 2010 Jan; 59(1):102-5. PubMed ID: 20931926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapsone hypersensitivity syndrome.
    Prussick R; Shear NH
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 2):346-9. PubMed ID: 8698924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innovative use of dapsone.
    Wozel VE
    Dermatol Clin; 2010 Jul; 28(3):599-610. PubMed ID: 20510768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reinstatement of dapsone following hypersensitivity.
    Labandeira J; Toribio J
    Acta Derm Venereol; 2003; 83(4):314-5. PubMed ID: 12926815
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixed drug eruption due to rifampin.
    John SS
    Lepr Rev; 1998 Dec; 69(4):397-9. PubMed ID: 9927813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal.
    Rao PN; Lakshmi TS
    Lepr Rev; 2001 Mar; 72(1):57-62. PubMed ID: 11355519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of leprosy.
    Boughton CR; Lloyd AR
    Med J Aust; 1987 Jun; 146(11):593-9. PubMed ID: 3302636
    [No Abstract]   [Full Text] [Related]  

  • 33. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
    Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
    Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed drug eruption - a sexually inducible reaction?
    Zawar V; Kirloskar M; Chuh A
    Int J STD AIDS; 2004 Aug; 15(8):560-3. PubMed ID: 15307969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed drug eruption in Bangladeshi population: confirmed by provocative test.
    Rahman MH
    Int J Dermatol; 2014 Feb; 53(2):255-8. PubMed ID: 23968227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
    Kaur J; Khandpur S; Seith A; Khanna N
    Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole.
    Gruber F; Stasić A; Lenković M; Brajac I
    Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fixed drug eruption induced by sulfaguanidine].
    Kastalli S; El Aidli S; Daghfous R; Trabelsi S; Lakhal M; Loueslati MH; Belkahia C
    Ann Dermatol Venereol; 2004 Apr; 131(4):382-4. PubMed ID: 15258515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapsone hypersensitivity syndrome among leprosy patients in China.
    Tian W; Shen J; Zhou M; Yan L; Zhang G
    Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.